Dr Jobe is a promising Clinician-Scientist involved in numerous on-going and planned studies (MEDiUM, RiboBP and PRIMORDIAL in submission)
Dr Jobe’s research interests are in the epidemiology and prevention of cardiovascular disease, especially in developing countries. He is seeking to understand the link between metabolic problems like obesity and insulin resistance, and the development of cardiovascular diseases. His current project, a randomised placebo-controlled trial, is a recall-by-genotype study which seeks to investigate the effect of riboflavin supplementation on blood pressure and possible effect modification by MTHFR C677T genotype.
Dr Jobe joined the MRCG as a Wellcome Trust Masters Fellow in Public Health and Tropical Medicine in September 2014 under the supervision of Professor Andrew Prentice to undertake an 18-month research project to investigate which of several mechanisms represents the most likely route(s) by which metabolic endotoxaemia leads to insulin resistance and diabetes.
He was one of the earliest cohort of doctors to emerge from the University of The Gambia (UTG) medical school. Subsequently, he went on to obtain a Diplôme d’Études Spécialisées (DES) de Cardiologie (Postgraduate Specialist Diploma in Cardiology) at Université Cheikh Anta Diop in Dakar, Senegal. He has also obtained an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine.
Dr Jobe is currently coordinating the non-communicable diseases (NCD) task force of the West African Global Health Alliance (WAGHA). He is bringing together a large team of professionals working in diverse areas and hoping to improve prevention and care in the developing world through high quality basic and translational research.
He has several peer-reviewed publications and has presented his research findings at major international conferences.